Nura teethcare

The repeat founders looking to disrupt oral care

Hello and welcome to Quick Pitch - the place to meet and learn about the hottest early stage startups in the European ecosystem.

If you’re a startup founder and want your startup to be featured in a Quick Pitch in front of hundreds of VCs and angels - fill out this form and we’ll get back to you!

Categorised as EIS/SEIS eligible

The UK’s EIS/ SEIS schemes are incredibly important for early stage startup funding, making the UK highly competitive for securing investment. At Quick Pitch we think it’s crucial to champion startups taking advantage of this super power even if pre-launch.

Today’s feature of Quick Pitch is an early-stage start up which is aiming to transform the oral care category into a high-end, premium category.

The Market

  • The total global oral care market is £39bn, of which UK toothpaste constitutes £860m. Premium toothpaste estimated to reach nearly £100m in the UK in the next 5 years.

This week's business solves two major problems: 

  • Oral Care in the UK has been dominated by a few big players who have failed to innovate.

  • This has led to a stagnant category where brands are not trusted, marketing is old fashioned and the science is out-dated.

One Liner

Nura is set to launch the “world’s most powerful toothpaste”, tested and developed with the University of Milan to:

  • Redefine how people perceive and interact with oral health

  • Establish a teeth-care brand that people love and champion

Quickfire

  • Headquarters: London

  • Employee count: 3

  • Investors: 7 angels

  • Funding amount: £113k

  • Business model: B2C Subscription

  • Traction metrics:

    • Pre-launch currently but in R&D testing nura performed almost 50% better than its leading competitor in enamel recovery and remineralisation.

    • All R&D that is core to nura’s product is already finished and validated, minimising the product effectiveness and usability risks that would delay or compromise launch

    • Socials to launch in early 2025 which we think will be very powerful for nura’s growth

Due Diligence

APPEALS

  • Rapidly growing market: Premium toothpaste is growing quickly as younger generations start to view oral care in the same way they do skin care - as a premium category worth investing in.

  • Very little disruption in this space: There has been little to no innovation or disruption in the toothpaste market, paving the way for new entrant to come in and grab market share through better products and fresh marketing.

POTENTIAL RISKS

  • Powerful incumbents: The current market leaders could adapt quickly and launch new formulations to try and retain market share

  • Untested category: Nura is seeking to redefine and premium-ise a whole category. As a result, there could end up being less demand for a high quality, expensive toothpaste than anticipated.

Competition

  • There are the incumbents who dominate (Colgate, Oral-B, Sensodyne) who have limited premium products.

  • There are also other younger premium toothpastes:

    • Aurezzi - Gold infused toothpaste

    • vVardis - Swiss company selling premium oral care products through dentists

    • Risewell - American company focusing on Natural Oral Care

Founders

  • Joe Jones - CEO, Built and ran a software spin-out, scaling from pre-revenue to >£25m of revenue and a team of 35 people

  • Issac Bailey - COO, Previously ops lead and employee #4 at Roam (VC-backed D2C sexual care startup)

  • Victor Palanaco - CMO, Former cofounder at Hipnos and chief of staff at a YC 21 B2B startup

Are you interested to invest in this startup?

Login or Subscribe to participate in polls.

Share to any investor, founder or friend that would find Quick Pitch interesting!

If you’re a startup founder and want your startup to be featured in a Quick Pitch in front of hundreds of VCs and angels - fill out this form and we’ll get back to you!

Reach out to us via LinkedIn here: Luke & Seb.

This newsletter is for informational purposes only and does not constitute financial advice. Quick Pitch is not regulated by the Financial Conduct Authority (FCA). The information provided should not be considered as a recommendation to buy, sell, or hold any investment. Readers are encouraged to conduct their own research and seek independent financial advice when required. Investing carries risks, and the value of investments can fall as well as rise. Quick Pitch assumes no liability for any decisions made based on the information provided in this newsletter.